Sociedad Española de Investigacion Ósea y Metabolismo Mineral

Revista de Osteoporosis y Metabolismo Mineral

Journal Metrics:
Citescore: 1,06 |  Academic Accelerator: 0,194 
SCImago Journal Rank : 0,12 | Google Scholar: 0,0172

Empresas Colaboradoras:

The Journal follows the Uniform Requirements standards Manuscripts Submitted to Biomedical for Journals www.icmje.org

The Journal embraces the principles and procedures dictated by the Committee on Publication Ethics (COPE) www.publicationethics.org

Author: Romm

Guidelines and recommendations from scientific societies and health institutions on COVID-19 infection and vitamin D

The intervention of vitamin D in our immune system activity led to the study of this hormone’s effect on SARS-CoV-2 infection from the start of the pandemic. Published studies have already been analyzed in other chapters of this special edition. Some societies and scientific and health institutions have considered this topic, and based on these reflections, offer recommendations to the health community. In this chapter, we present a brief overview.

Read More

Towards an individualised approach to management of osteoporosis

The treatment and management of osteoporosis, like any other disease, should be evidence-based in order to give the patients the best chance of limiting the consequences of the disease. Osteoporosis is a very common condition, affecting more women than men, and often overlooked and undertreated. The updated clinical practice guideline on postmenopausal, glucocorticoid induced, and male osteoporosis from the Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM) [1] is an important tool for clinicians with respect to diagnosis, future fracture risk assessment, and treatment of osteoporosis.
The diagnostic criteria are based on DXA and the presence of fractures, the criteria are not new, but the emphasis on recent fractures is new and worth noticing. A patient with a prior major osteoporotic fracture has a higher risk of fracture than a person at the same age without a fracture for up to 10 years following the first fracture, however, the risk in the 2 years immediately following the fracture is several times higher [2]. Therefore, the period following a fracture is a window of opportunity for prevention of the next fracture. The Fracture Liaison Service concept was developed to reduce the worldwide gap in fracture patients being assessed for osteoporosis.

Read More

Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)*. Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM)

Seven years have passed since the most recent version of the Osteoporosis Guidelines of the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM) was drawn up, using the standard methodology of evidence‐based medicine [1]. This update incorporates information released since then. The full text is available in the Guide.

2. Methods
A group of experts (see annexe) reviewed each section to incorporate the new findings published in recent years. The new text was disseminated to other interested entities (including SEIOMM partners, patient associations, the Spanish Agency for Medicines and Health Products, and pharmaceutical industries) to provide input to the document, which was subsequently analysed by the group of experts. Osteoporosis in postmenopausal women was analysed first, followed by osteoporosis in men and glucocorticoid‐induced osteoporosis.

Read More

Clinical practice guidelines for postmenopausal, glucocorticoid-induced and male osteoporosis: 2022 update. Spanish Society for Bone and Mineral Metabolism Research (SEIOMM)

Seven years have passed since the publication of the previous version of the Osteoporosis Guidelines of the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM) that was created in accordance with the standard methodology of evidence‐based medicine [1]. This update incorporates the most essential information that has appeared since the publication of the previous version, with particular reference to new diagnostic procedures and therapeutic options. Novel diagnostic modalities discussed in these guidelines include the Trabecular Bone Score (TBS) and the detection of vertebral fractures by densitometry. Among the therapeutic options, we discuss the use of novel anabolic drugs (abaloparatide and romosozumab). Studies that compare the efficacy of various drug regimens for the treatment of severe osteoporosis are also considered. Likewise, the guidelines for action after the withdrawal of antiresorptive drugs and other sequential and combined treatment schemes are assessed.

Read More

Differential inflammatory environment in patients with osteoporosis and type 2 diabetes mellitus

Diabetes mellitus (DM2) and osteoporosis are increasing prevalence diseases due to the aging of the population, and gender, genetic and environmental factors, such as an unbalanced diet, obesity and a sedentary life. DM2 increased alarmingly in 2014, affecting more than 420 million people worldwide [1]. Patients with DM2 present a higher risk of falls and increased prevalence and incidence of fragility fractures have been observed in these patients [2-5], causing significant mortality, morbidity and increased healthcare costs.
DM2 affects bone homeostasis [6,7], and is associated with a higher risk of fractures [8], despite the fact that patients exhibit higher bone mineral density (BMD) [4,9-12]. Furthermore, reduced circulating levels of bone turnover markers have been observed in DM2 [13], which should influence the high fracture risk in patients with DM2.

Read More

Buscador

Generic selectors
Solo mostrar coincidencias exactas
Buscar en títulos
Buscar en cuerpo de texto
Filtrar por categorías
11
12
120181004-en
120191101-en
120191102-en
120191104-en
120201201-en
120201202-en
120201203-en
120201204-en
120211301-en
120211302-en
120211304-en
120221401-en
120221402-en
13
14
920191101-en
920211301-en
920211302-en
920221401-en
Brief Original
Clinical Notes
Committees
Editorial
English
Index of Authors
Index of Communications
Letter to the Director
Letter to the Editor
Oral Communications
Original Articles
Osteology images
Position Paper
Poster Communications
Presentation
Reviews
SIBOMM News
Special Article
Special Documents

Search

Generic selectors
Solo mostrar coincidencias exactas
Buscar en títulos
Buscar en cuerpo de texto
Filtrar por categorías
11
12
120181004-en
120191101-en
120191102-en
120191104-en
120201201-en
120201202-en
120201203-en
120201204-en
120211301-en
120211302-en
120211304-en
120221401-en
120221402-en
13
14
920191101-en
920211301-en
920211302-en
920221401-en
Brief Original
Clinical Notes
Committees
Editorial
English
Index of Authors
Index of Communications
Letter to the Director
Letter to the Editor
Oral Communications
Original Articles
Osteology images
Position Paper
Poster Communications
Presentation
Reviews
SIBOMM News
Special Article
Special Documents

Language

Search